Chapters
Chapter 1
General introduction and scope of the thesis
Chapter 2
Whole genome sequencing identi!es patient-speci!c DNA minimal residual disease markers in neuroblastoma.
J Mol Diagn 2015; 17(1):43-52.
Chapter 3
Epithelial to mesenchymal transition and minimal residual disease monitoring in neuroblastoma.
Chapter 4
Circulating tumor DNA for disease monitoring in neuroblastoma.
Chapter 5
Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma.
Pediatr Blood Cancer 2015; 62(8):1368-73.
Chapter 6
Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localized neuroblastoma patients.
Eur J Cancer 2016; 54:149-58.
Chapter 7
Interim analysis of the prospective minimal residual disease monitoring study in high risk neuroblastoma
Chapter 8
General discussion
